Hiroyuki Yuasa Selected Research

hippocampal cholinergic neurostimulating peptide

7/2007	Differential expression of HCNP-related antigens in hippocampus in senescence-accelerated mice.
2/2002	Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Yuasa Research Topics

Disease

3	Dementia (Dementias) 01/2022 - 02/2002
2	Infections 05/2021 - 01/2015
2	Headache (Headaches) 01/2020 - 06/2018
2	Vasculitis (Vasculitides) 09/2019 - 07/2018
1	REM Sleep Behavior Disorder 01/2022
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2022
1	Glioma (Gliomas) 01/2022
1	Gliosis 01/2022
1	Multiple System Atrophy 01/2022
1	CADASIL 08/2021
1	Subacute Combined Degeneration 01/2021
1	Myelitis 01/2021
1	Migraine Disorders (Migraine) 01/2020
1	Atrophy 11/2019
1	Lymphoma (Lymphomas) 07/2018
1	Primary angiitis of the central nervous system 07/2018
1	Abscess 06/2018
1	Central Nervous System Cysts (Suprasellar Cyst) 06/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Myotonia 10/2016
1	Cytomegalovirus Infections (Inclusion Disease) 01/2015
1	Myocarditis (Carditis) 01/2015
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2015
1	Hypesthesia (Numbness) 01/2015
1	Leukocytosis (Pleocytosis) 01/2015
1	Intracranial Embolism 01/2015
1	Eosinophilia 01/2015
1	Guillain-Barre Syndrome 01/2015
1	Encephalitis (Encephalitis, Rasmussen) 01/2013
1	Hypohidrosis 10/2012
1	Autonomic Nervous System Diseases (Dysautonomia) 10/2012
1	Orthostatic Hypotension (Postural Hypotension) 10/2012
1	Stroke (Strokes) 01/2010
1	Ischemic Stroke 01/2010
1	Muscular Atrophy (Muscle Atrophy) 01/2010
1	Hypophysitis 08/2006
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 08/2006
1	Neoplasms (Cancer) 04/2005
1	Breast Neoplasms (Breast Cancer) 04/2005
1	Sepsis (Septicemia) 01/2003
1	Liver Diseases (Liver Disease) 01/2003
1	Endotoxemia 01/2003
1	Alzheimer Disease (Alzheimer's Disease) 02/2002
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
2	hippocampal cholinergic neurostimulating peptideIBA 07/2007 - 02/2002
1	Leucine (L-Leucine)FDA Link 01/2022
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2022
1	alpha-SynucleinIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 08/2021
1	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	Topiramate (Topamax)FDA LinkGeneric 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	SteroidsIBA 09/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2018
1	GadoliniumIBA 07/2018
1	ChloridesIBA 10/2016
1	Sodium Channels (Sodium Channel)IBA 10/2016
1	EnzymesIBA 01/2015
1	Immunoglobulin M (IgM)IBA 01/2015
1	AnticoagulantsIBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2015
1	Cholinergic Agents (Cholinergics)IBA 10/2012
1	EdaravoneIBA 01/2010
1	N-Methylaspartate (NMDA)IBA 07/2007
1	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2005
1	formycin diphosphate (FDP)IBA 01/2003
1	LipopolysaccharidesIBA 01/2003
1	ThrombomodulinIBA 01/2003
1	Fibrin Fibrinogen Degradation ProductsIBA 01/2003
1	FibrinIBA 01/2003
1	Messenger RNA (mRNA)IBA 02/2002
1	Phosphatidylethanolamine Binding ProteinIBA 02/2002

Therapy/Procedure

7	Therapeutics 09/2019 - 04/2005
1	Punctures 01/2017
1	Intravenous Administration 01/2015
1	Intravenous Infusions 01/2010
1	Modified Radical Mastectomy (Mastectomy, Modified) 04/2005
1	Neoadjuvant Therapy 04/2005
1	Intraperitoneal Injections 01/2003